Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 100.00% is in line with its 5-year average of 100.00%, near the high end of its 5-year range (97.21%–100.00%).
As of the fiscal period ended Tuesday, June 30, 2026. In line with its 12-month average of 100.00%.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 100.00%.
GROSS MARGIN
100.00%
GROSS MARGIN AVG TTM
100.00%
GROSS MARGIN AVG 3Y
100.00%
GROSS MARGIN AVG 5Y
100.00%
GROSS MARGIN AVG 10Y
70.25%
GROSS MARGIN AVG 15Y
58.46%
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
0.00%
CURRENT VS 3Y AVG
0.00%
CURRENT VS 5Y AVG
0.00%
CURRENT VS 10Y AVG
+42.34%
CURRENT VS 15Y AVG
+71.05%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.38%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+141.66%
vs the sector median at left
Xenetic Biosciences, Inc.
Market Cap
$4.81M
Gross Margin
100.00%
TTM Avg
100.00%
3Y Avg
100.00%
5Y Avg
100.00%
Market Cap
$4.90M
Gross Margin
19.34%
TTM Avg
59.23%
3Y Avg
54.62%
5Y Avg
36.41%
Market Cap
$4.95M
Gross Margin
100.00%
TTM Avg
99.28%
3Y Avg
89.13%
5Y Avg
81.38%
Market Cap
$5.03M
Gross Margin
77.68%
TTM Avg
77.66%
3Y Avg
77.69%
5Y Avg
77.69%
Market Cap
$4.59M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$4.51M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$5.12M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | $4.81M | 100.00% | 100.00% | 100.00% | 100.00% |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.90M | 19.34% | 59.23% | 54.62% | 36.41% |
| Lexaria Bioscience Corp. (LEXX)vs › | $4.95M | 100.00% | 99.28% | 89.13% | 81.38% |
| CalciMedica, Inc. (CALC)vs › | $4.60M | 0.00% | 0.00% | 0.00% | 0.00% |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.03M | 77.68% | 77.66% | 77.69% | 77.69% |
| PharmaCyte Biotech, Inc. (PMCB)vs › | $4.59M | 0.00% | 0.00% | 0.00% | 0.00% |
| Imunon, Inc. (IMNN)vs › | $5.08M | 0.00% | 0.00% | 25.00% | 50.00% |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.51M | 0.00% | 0.00% | 0.00% | 0.00% |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $5.12M | 0.00% | 0.00% | 0.00% | 0.00% |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.37M | 26.32% | -195.38% | -178.16% | -96.97% |
Gross Margin
100.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 100.00% |
| 2026-03-31 | 100.00% |
| 2025-12-31 | 100.00% |
| 2025-09-30 | 100.00% |
| 2025-06-30 | 100.00% |
| 2025-03-31 | 100.00% |
| 2024-12-31 | 100.00% |
| 2024-09-30 | 100.00% |
| 2024-06-30 | 100.00% |
| 2024-03-31 | 100.00% |
| 2023-12-31 | 100.00% |
| 2023-09-30 | 100.00% |
| 2023-06-30 | 100.00% |
| 2023-03-31 | 100.00% |
| 2022-12-31 | 100.00% |
| 2022-09-30 | 98.08% |
| 2022-06-30 | 100.00% |
| 2022-03-31 | 100.00% |
| 2021-12-31 | 97.21% |
| 2021-09-30 | 100.00% |
| 2021-06-30 | 100.00% |
| 2021-03-31 | 100.00% |
| 2020-12-31 | 100.00% |
| 2020-09-30 | 100.00% |
| 2020-06-30 | 100.00% |
| 2020-03-31 | 100.00% |
| 2019-12-31 | 100.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 99.21% |
| 2017-09-30 | -14.15% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 100.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 100.00% |
| 2013-08-31 | -23.52% |
| 2013-05-31 | 74.81% |
| 2013-02-28 | 89.24% |
| 2012-11-30 | 63.79% |
| 2012-08-31 | 15.84% |
| 2012-05-31 | 72.80% |
| 2012-02-29 | 76.03% |
| 2011-11-30 | 100.00% |
